Anzinger Str. 7a
Eurofins Medigenomix is a competence center for genetic analyses of the Eurofins Scientific Group. The company successfully expanded its service portfolio by the addition of services in the areas of pharmacogenetics and pharmacogenomics. Eurofins Medigenomix offers a comprehensive Pharma services portfolio for the entire drug development process, from preclinical research to clinical phase III trials e.g. DNA/RNA preparation, genotyping, polymorphism screening, biomarker analysis, residual DNA testing, expression analysis, assay development & validation, transcriptome analysis, metagenomic approaches and exclusive marker set for the general identification of responder/non-responder in the scope of clinical studies. Eurofins Medigenomix is certified according to ISO 9001 and ISO 17025, and audited by pharmaceutical clients for GxP.